Stop Infliximab in Patients With Crohn's Disease

NCT00571337 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Infliximab

Sponsor

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives